Skip to content

The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination

The Effect of Extended Yellow Fever Vaccine Information on Symptom Reports Following Vaccination

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00708630
Enrollment
100
Registered
2008-07-02
Start date
2008-06-30
Completion date
2008-12-31
Last updated
2012-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vaccination

Keywords

yellow fever vaccine, patient information, symptom reports, patient satisfaction

Brief summary

This study aims to investigate the effect of providing additional information about possible mild side effects of the yellow fever vaccination on the reporting of physical symptoms. Additionally, the project aims to investigate the relationship between individual characteristics (trait anxiety and perceived sensitivity to medication) and the reporting of physical symptoms, as well as possible interactions between the level of information provided and individual characteristics. We hypothesize that more information about mild symptoms provided to participants will increase the number of reported symptoms after vaccination.

Interventions

BEHAVIORALExtended information on side effects

More detailed information on possible side effects of vaccine

Sponsors

University of Auckland, New Zealand
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Receiving yellow fever vaccination * English speaker * Aged over 18

Exclusion criteria

* No phone for follow-up

Design outcomes

Primary

MeasureTime frame
symptom report scale20 minutes and 1 week post vaccination

Secondary

MeasureTime frame
patient satisfaction scale20 minutes and 1 week post vaccination

Countries

New Zealand

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026